nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—DRD2—Gilles de la Tourette syndrome	0.432	0.564	CbGaD
Doxepin—HTR2A—Gilles de la Tourette syndrome	0.334	0.436	CbGaD
Doxepin—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00539	0.0799	CbGeAlD
Doxepin—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00324	0.048	CbGeAlD
Doxepin—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00158	0.0234	CbGeAlD
Doxepin—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.00152	0.0226	CbGeAlD
Doxepin—HTR6—nervous system—Gilles de la Tourette syndrome	0.00141	0.021	CbGeAlD
Doxepin—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00136	0.0202	CbGeAlD
Doxepin—HRH2—nervous system—Gilles de la Tourette syndrome	0.00129	0.0192	CbGeAlD
Doxepin—HRH2—central nervous system—Gilles de la Tourette syndrome	0.00125	0.0185	CbGeAlD
Doxepin—CHRM5—nervous system—Gilles de la Tourette syndrome	0.00124	0.0183	CbGeAlD
Doxepin—CHRM4—brain—Gilles de la Tourette syndrome	0.00121	0.0179	CbGeAlD
Doxepin—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.00119	0.0176	CbGeAlD
Doxepin—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00113	0.0167	CbGeAlD
Doxepin—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.0011	0.0164	CbGeAlD
Doxepin—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00109	0.0161	CbGeAlD
Doxepin—HTR6—brain—Gilles de la Tourette syndrome	0.00108	0.016	CbGeAlD
Doxepin—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00106	0.0158	CbGeAlD
Doxepin—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000994	0.0147	CbGeAlD
Doxepin—HRH2—brain—Gilles de la Tourette syndrome	0.000989	0.0146	CbGeAlD
Doxepin—CHRM5—brain—Gilles de la Tourette syndrome	0.000944	0.014	CbGeAlD
Doxepin—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.000943	0.014	CbGeAlD
Doxepin—ORM1—nervous system—Gilles de la Tourette syndrome	0.000909	0.0135	CbGeAlD
Doxepin—ORM1—central nervous system—Gilles de la Tourette syndrome	0.000876	0.013	CbGeAlD
Doxepin—ADRA1B—brain—Gilles de la Tourette syndrome	0.000863	0.0128	CbGeAlD
Doxepin—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000848	0.0126	CbGeAlD
Doxepin—ADRA1D—brain—Gilles de la Tourette syndrome	0.000844	0.0125	CbGeAlD
Doxepin—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000837	0.0124	CbGeAlD
Doxepin—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000817	0.0121	CbGeAlD
Doxepin—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000817	0.0121	CbGeAlD
Doxepin—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000787	0.0117	CbGeAlD
Doxepin—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000775	0.0115	CbGeAlD
Doxepin—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000772	0.0114	CbGeAlD
Doxepin—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000768	0.0114	CbGeAlD
Doxepin—DRD2—midbrain—Gilles de la Tourette syndrome	0.000756	0.0112	CbGeAlD
Doxepin—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000746	0.0111	CbGeAlD
Doxepin—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000745	0.011	CbGeAlD
Doxepin—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000743	0.011	CbGeAlD
Doxepin—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000739	0.011	CbGeAlD
Doxepin—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000735	0.0109	CbGeAlD
Doxepin—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000691	0.0102	CbGeAlD
Doxepin—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000688	0.0102	CbGeAlD
Doxepin—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.000682	0.0101	CbGeAlD
Doxepin—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000665	0.00986	CbGeAlD
Doxepin—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000662	0.00982	CbGeAlD
Doxepin—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000657	0.00973	CbGeAlD
Doxepin—CHRM2—brain—Gilles de la Tourette syndrome	0.000648	0.00961	CbGeAlD
Doxepin—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000634	0.0094	CbGeAlD
Doxepin—HTR2C—brain—Gilles de la Tourette syndrome	0.000625	0.00926	CbGeAlD
Doxepin—DRD2—nervous system—Gilles de la Tourette syndrome	0.000622	0.00921	CbGeAlD
Doxepin—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000613	0.00908	CbGeAlD
Doxepin—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000611	0.00905	CbGeAlD
Doxepin—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000604	0.00896	CbGeAlD
Doxepin—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000599	0.00887	CbGeAlD
Doxepin—SLC6A4—brain—Gilles de la Tourette syndrome	0.000592	0.00878	CbGeAlD
Doxepin—CHRM1—brain—Gilles de la Tourette syndrome	0.00059	0.00874	CbGeAlD
Doxepin—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.00059	0.00874	CbGeAlD
Doxepin—HTR2B—brain—Gilles de la Tourette syndrome	0.000587	0.0087	CbGeAlD
Doxepin—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000587	0.00869	CbGeAlD
Doxepin—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000582	0.00862	CbGeAlD
Doxepin—CHRM3—brain—Gilles de la Tourette syndrome	0.000528	0.00782	CbGeAlD
Doxepin—HTR1A—brain—Gilles de la Tourette syndrome	0.000526	0.00779	CbGeAlD
Doxepin—SLC6A2—brain—Gilles de la Tourette syndrome	0.000521	0.00773	CbGeAlD
Doxepin—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000499	0.00739	CbGeAlD
Doxepin—HRH1—nervous system—Gilles de la Tourette syndrome	0.000491	0.00727	CbGeAlD
Doxepin—ADRA1A—brain—Gilles de la Tourette syndrome	0.000485	0.00718	CbGeAlD
Doxepin—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000482	0.00715	CbGeAlD
Doxepin—DRD2—brain—Gilles de la Tourette syndrome	0.000475	0.00704	CbGeAlD
Doxepin—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000473	0.007	CbGeAlD
Doxepin—KCNH2—brain—Gilles de la Tourette syndrome	0.000468	0.00694	CbGeAlD
Doxepin—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000464	0.00688	CbGeAlD
Doxepin—ADRA2C—brain—Gilles de la Tourette syndrome	0.000462	0.00685	CbGeAlD
Doxepin—Cyclobenzaprine—HTR2A—Gilles de la Tourette syndrome	0.00046	0.063	CrCbGaD
Doxepin—Chlorprothixene—DRD3—Gilles de la Tourette syndrome	0.00045	0.0616	CrCbGaD
Doxepin—HTR2A—nervous system—Gilles de la Tourette syndrome	0.00041	0.00608	CbGeAlD
Doxepin—Promazine—DRD4—Gilles de la Tourette syndrome	0.000408	0.0559	CrCbGaD
Doxepin—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.000396	0.0542	CrCbGaD
Doxepin—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000395	0.00585	CbGeAlD
Doxepin—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.000387	0.053	CrCbGaD
Doxepin—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00038	0.00562	CbGeAlD
Doxepin—HRH1—brain—Gilles de la Tourette syndrome	0.000375	0.00556	CbGeAlD
Doxepin—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000374	0.00554	CbGeAlD
Doxepin—ADRA2A—brain—Gilles de la Tourette syndrome	0.000369	0.00546	CbGeAlD
Doxepin—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000365	0.00542	CbGeAlD
Doxepin—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00036	0.00533	CbGeAlD
Doxepin—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000338	0.0463	CrCbGaD
Doxepin—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000327	0.00484	CbGeAlD
Doxepin—HTR2A—brain—Gilles de la Tourette syndrome	0.000313	0.00464	CbGeAlD
Doxepin—Chlorprothixene—DRD2—Gilles de la Tourette syndrome	0.000311	0.0426	CrCbGaD
Doxepin—Amitriptyline—DRD3—Gilles de la Tourette syndrome	0.000306	0.042	CrCbGaD
Doxepin—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.000306	0.0419	CrCbGaD
Doxepin—Nortriptyline—DRD2—Gilles de la Tourette syndrome	0.000306	0.0418	CrCbGaD
Doxepin—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.000288	0.0394	CrCbGaD
Doxepin—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000287	0.0393	CrCbGaD
Doxepin—CYP2D6—brain—Gilles de la Tourette syndrome	0.000286	0.00423	CbGeAlD
Doxepin—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000277	0.0379	CrCbGaD
Doxepin—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000269	0.00398	CbGeAlD
Doxepin—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000259	0.00383	CbGeAlD
Doxepin—Desipramine—DRD2—Gilles de la Tourette syndrome	0.000252	0.0344	CrCbGaD
Doxepin—Promazine—DRD2—Gilles de la Tourette syndrome	0.000244	0.0334	CrCbGaD
Doxepin—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000242	0.0331	CrCbGaD
Doxepin—Chlorprothixene—HTR2A—Gilles de la Tourette syndrome	0.000241	0.0329	CrCbGaD
Doxepin—Nortriptyline—HTR2A—Gilles de la Tourette syndrome	0.000236	0.0323	CrCbGaD
Doxepin—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.000222	0.0304	CrCbGaD
Doxepin—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000214	0.0293	CrCbGaD
Doxepin—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000213	0.0292	CrCbGaD
Doxepin—Amitriptyline—DRD2—Gilles de la Tourette syndrome	0.000212	0.029	CrCbGaD
Doxepin—ABCB1—brain—Gilles de la Tourette syndrome	0.000205	0.00304	CbGeAlD
Doxepin—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.000194	0.0266	CrCbGaD
Doxepin—Promazine—HTR2A—Gilles de la Tourette syndrome	0.000188	0.0258	CrCbGaD
Doxepin—Imipramine—HTR2A—Gilles de la Tourette syndrome	0.000165	0.0226	CrCbGaD
Doxepin—Amitriptyline—HTR2A—Gilles de la Tourette syndrome	0.000164	0.0224	CrCbGaD
Doxepin—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.16e-05	0.000386	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	6.09e-05	0.000382	CbGpPWpGaD
Doxepin—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.99e-05	0.000375	CbGpPWpGaD
Doxepin—HRH4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.96e-05	0.000374	CbGpPWpGaD
Doxepin—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.9e-05	0.00037	CbGpPWpGaD
Doxepin—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.87e-05	0.000368	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.82e-05	0.000365	CbGpPWpGaD
Doxepin—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.79e-05	0.000363	CbGpPWpGaD
Doxepin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.77e-05	0.000362	CbGpPWpGaD
Doxepin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.75e-05	0.000361	CbGpPWpGaD
Doxepin—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.74e-05	0.00036	CbGpPWpGaD
Doxepin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.7e-05	0.000357	CbGpPWpGaD
Doxepin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.68e-05	0.000356	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.65e-05	0.000354	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.63e-05	0.000353	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.6e-05	0.000351	CbGpPWpGaD
Doxepin—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.58e-05	0.00035	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.57e-05	0.000349	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.56e-05	0.000349	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.46e-05	0.000343	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.44e-05	0.000341	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.41e-05	0.000339	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.4e-05	0.000339	CbGpPWpGaD
Doxepin—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.3e-05	0.000332	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.28e-05	0.000331	CbGpPWpGaD
Doxepin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.28e-05	0.000331	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.26e-05	0.00033	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.24e-05	0.000328	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.13e-05	0.000322	CbGpPWpGaD
Doxepin—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.12e-05	0.000321	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.11e-05	0.000321	CbGpPWpGaD
Doxepin—HRH2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.09e-05	0.000319	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.09e-05	0.000319	CbGpPWpGaD
Doxepin—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.09e-05	0.000319	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.08e-05	0.000319	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.06e-05	0.000318	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.06e-05	0.000317	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.04e-05	0.000316	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.03e-05	0.000315	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.96e-05	0.000311	CbGpPWpGaD
Doxepin—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.95e-05	0.00031	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.91e-05	0.000308	CbGpPWpGaD
Doxepin—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.87e-05	0.000306	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.78e-05	0.0003	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.76e-05	0.000298	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.74e-05	0.000297	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.73e-05	0.000296	CbGpPWpGaD
Doxepin—HRH2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.62e-05	0.00029	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.62e-05	0.00029	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.62e-05	0.00029	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.59e-05	0.000288	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.57e-05	0.000287	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.56e-05	0.000286	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.54e-05	0.000285	CbGpPWpGaD
Doxepin—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.49e-05	0.000282	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.43e-05	0.000278	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.42e-05	0.000277	CbGpPWpGaD
Doxepin—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.41e-05	0.000277	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.41e-05	0.000276	CbGpPWpGaD
Doxepin—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.4e-05	0.000276	CbGpPWpGaD
Doxepin—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.38e-05	0.000275	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.35e-05	0.000273	CbGpPWpGaD
Doxepin—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.34e-05	0.000272	CbGpPWpGaD
Doxepin—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.33e-05	0.000271	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.31e-05	0.00027	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	4.31e-05	0.00027	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.3e-05	0.00027	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.29e-05	0.000269	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.29e-05	0.000269	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.28e-05	0.000268	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.22e-05	0.000265	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	4.21e-05	0.000264	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.19e-05	0.000263	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.17e-05	0.000261	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.14e-05	0.00026	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.13e-05	0.000259	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.12e-05	0.000259	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.11e-05	0.000258	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.02e-05	0.000252	CbGpPWpGaD
Doxepin—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.02e-05	0.000252	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.01e-05	0.000252	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.01e-05	0.000251	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4e-05	0.000251	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.99e-05	0.00025	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	3.97e-05	0.000249	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.95e-05	0.000248	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.94e-05	0.000247	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.93e-05	0.000247	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	3.93e-05	0.000247	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.93e-05	0.000247	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.92e-05	0.000246	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.91e-05	0.000245	CbGpPWpGaD
Doxepin—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.91e-05	0.000245	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.9e-05	0.000245	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.89e-05	0.000244	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.89e-05	0.000244	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.88e-05	0.000243	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.87e-05	0.000243	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.86e-05	0.000242	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.83e-05	0.00024	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.83e-05	0.00024	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.82e-05	0.00024	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.81e-05	0.000239	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.8e-05	0.000238	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.76e-05	0.000236	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.75e-05	0.000235	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.75e-05	0.000235	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.73e-05	0.000234	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.68e-05	0.000231	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.64e-05	0.000228	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.63e-05	0.000227	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.59e-05	0.000225	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.58e-05	0.000225	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.57e-05	0.000224	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.57e-05	0.000224	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.57e-05	0.000224	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.57e-05	0.000224	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.56e-05	0.000223	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.56e-05	0.000223	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.55e-05	0.000223	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.55e-05	0.000222	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.55e-05	0.000222	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.54e-05	0.000222	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.53e-05	0.000222	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.53e-05	0.000221	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.52e-05	0.000221	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.52e-05	0.00022	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.51e-05	0.00022	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.5e-05	0.00022	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.49e-05	0.000219	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.48e-05	0.000218	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.48e-05	0.000218	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.47e-05	0.000218	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.46e-05	0.000217	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.45e-05	0.000216	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.41e-05	0.000214	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.4e-05	0.000213	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	3.36e-05	0.000211	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.35e-05	0.00021	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.32e-05	0.000208	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.31e-05	0.000207	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.26e-05	0.000204	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.24e-05	0.000203	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.24e-05	0.000203	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.24e-05	0.000203	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.23e-05	0.000203	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.22e-05	0.000202	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.21e-05	0.000201	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.21e-05	0.000201	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.2e-05	0.000201	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.18e-05	0.000199	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.17e-05	0.000199	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.16e-05	0.000198	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	3.13e-05	0.000196	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.12e-05	0.000196	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.03e-05	0.00019	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.02e-05	0.000189	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.01e-05	0.000189	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.99e-05	0.000188	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.99e-05	0.000188	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.99e-05	0.000187	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.95e-05	0.000185	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.93e-05	0.000184	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.9e-05	0.000182	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.89e-05	0.000181	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.88e-05	0.00018	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.82e-05	0.000177	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.81e-05	0.000176	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.8e-05	0.000175	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.75e-05	0.000173	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.73e-05	0.000171	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.73e-05	0.000171	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.73e-05	0.000171	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.72e-05	0.000171	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.7e-05	0.000169	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.63e-05	0.000165	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.61e-05	0.000164	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	2.59e-05	0.000163	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.54e-05	0.000159	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.54e-05	0.000159	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.54e-05	0.000159	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.54e-05	0.000159	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.5e-05	0.000157	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.49e-05	0.000156	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.48e-05	0.000156	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.48e-05	0.000155	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.46e-05	0.000154	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.45e-05	0.000154	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000154	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.45e-05	0.000153	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.44e-05	0.000153	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000149	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.37e-05	0.000149	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.36e-05	0.000148	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.33e-05	0.000146	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.31e-05	0.000145	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.3e-05	0.000144	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.29e-05	0.000144	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.27e-05	0.000142	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.26e-05	0.000142	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.26e-05	0.000142	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.26e-05	0.000141	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.000141	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.23e-05	0.00014	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.22e-05	0.000139	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.21e-05	0.000139	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.2e-05	0.000138	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.15e-05	0.000135	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.14e-05	0.000134	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.12e-05	0.000133	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.11e-05	0.000132	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.11e-05	0.000132	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.1e-05	0.000132	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.1e-05	0.000132	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.1e-05	0.000131	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.09e-05	0.000131	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.08e-05	0.00013	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.07e-05	0.00013	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.06e-05	0.000129	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.05e-05	0.000129	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.05e-05	0.000128	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.04e-05	0.000128	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.04e-05	0.000128	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.02e-05	0.000126	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.01e-05	0.000126	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.98e-05	0.000124	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.92e-05	0.000121	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.91e-05	0.00012	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.91e-05	0.00012	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.91e-05	0.00012	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.9e-05	0.000119	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.9e-05	0.000119	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.89e-05	0.000119	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.88e-05	0.000118	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.87e-05	0.000117	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.87e-05	0.000117	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.78e-05	0.000112	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.74e-05	0.000109	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.61e-05	0.000101	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.55e-05	9.73e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.54e-05	9.68e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.5e-05	9.41e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.48e-05	9.26e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.36e-05	8.54e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.34e-05	8.38e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.33e-05	8.36e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.33e-05	8.33e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.32e-05	8.25e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.31e-05	8.23e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.22e-05	7.64e-05	CbGpPWpGaD
